UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058
Washington, D.C. 20549 Expires: May 31, 1997
Estimated average burden
hours per response....2.50
FORM 12b-25 SEC FILE NUMBER
0-15936
NOTIFICATION OF LATE FILING CUSIP NUMBER
422 19F 105
(CHECK ONE): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q [ ] Form N-SAR
For Period Ended: 2/28/98
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
READ INSTRUCTION (ON BACK PAGE) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
HEALTH OUTCOMES MANAGEMENT, INC.
- --------------------------------------------------------------------------------
Full Name of Registrant
- --------------------------------------------------------------------------------
Former Name if Applicable
2331 UNIVERSITY AVENUE S.E.
- --------------------------------------------------------------------------------
Address of Principal Executive Office (STREET AND NUMBER)
MINNEAPOLIS, MN 55414
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
| (a) The reasons described in reasonable detail in Part III of this
| form could not be eliminated without unreasonable effort or
| expense;
| (b) The subject annual report, semi-annual report, transition
| report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
| thereof, will be filed on or before the fifteenth calendar day
[X] | following the prescribed due date; or the subject quarterly
| report of transition report on Form 10-Q, or portion thereof
| will be filed on or before the fifth calendar day following
| the prescribed due date; and
| (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
The 10-KSB could not be filed on a timely basis due to the Company's recent
change of auditors. the new audit firm was engaged on May 4, 1998 as
indicated by the Company's 8-K filing dated as such. Due to the newness of
the firm and the complexity of issues related to the discontinuation of the
Company's retail pharmacy business segment, the Company's new auditors have
not yet had ample time to complete the Company's Financial Statements and
issue their report. See Accountant's statement attached.
(ATTACH EXTRA SHEETS IF NEEDED)
<PAGE>
SEC 1344
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
JANNA R. SEVERANCE 612 347-0367
--------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If answer
is no, identify report(s). [X] Yes [ ] No
--------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or portion
thereof? [X] Yes [ ] No
--------------------------------------------------------------------------
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
The report will contain the one time impact of the discontinuation of the
firm's retail pharmacy business. No quantitative estimates of the impact
of this item are currently available.
- --------------------------------------------------------------------------------
HEALTH OUTCOMES MANAGEMENT, INC.
-------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date MAY 28, 1998 By /s/ PETER ZUGSCHWERT
------------------ --------------------------------------------------
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
VIOLATIONS (SEE 18 U.S.C. 1001).
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in
or filed with the form will be made a matter of public record in the
Commission files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities of
the registrant is registered.
4. Amendments to the notifications must also be filed on Form 12b-25 but need
to restate information that has been correctly furnished. The form shall be
clearly identified as an amended notification.
5. ELECTRONIC FILERS. This form shall not be used by electronic filers unable
to timely file a report solely due to electronic difficulties. Filers
unable to submit a report within the time period prescribed due to
difficulties in electronic filing should comply with either Rule 201 or
Rule 202 of Regulation S-T (ss.232.201 or ss.232.202 of this chapter) or
apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
S-T (ss.232.13(b) of this chapter).
<PAGE>
May 27, 1998
Mr. Peter Zugschwert
Health Outcomes Management, Inc.
2331 University Avenue Southeast
Minneapolis, MN 55414
Dear Mr. Zugschwert:
This letter is to advise you that our audit report relating to the Company's
year-end February 28, 1998 financial statement will not be available to file
the 10-KSB on a timely basis. The delay in completing the audit is due to our
recent appointment as the Company's auditor, certain reporting complexities,
including the reclassification of prior financial information for the
discontinued operations of your retail pharmacy business, and issues in
coordinating timing to obtaining information from the prior auditors.
We sincerely regret the delay in the preparation of the financial statement, but
we know that you understand the need for filing complete and accurate
information.
Sincerely,
SCHWEITZER RUBIN KARON & BREMER
Certified Public Accountants
Malcolm W. McDermid
MMc/mjd
